🔎 Trials Near Me

Dachaigh › Galar Ae Steatotic › New York › New York City

Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an New York City, NY

Tha 16 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann agus timcheall air New York City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

A’ fastadhÌre 3
  • 89bio Clinical Study Site, New York
  • 89bio Clinical Study Site, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A’ fastadhÌre 3
  • 89bio Clinical Study Site, New York
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06318169

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

A’ fastadhÌre 2
  • New York Presbyterian/Weill Cornell, New York
  • Columbia University Iriving School of Medicine, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

A’ fastadhÌre 2
  • Columbia University Irving Medical Center, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

A’ fastadhÌre 3
  • NYU Langone Health, New York
  • IMA Clinical Research Manhattan, New York
  • New York Gastroenterology Associates, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

A’ fastadhÌre 3
  • Akero Clinical Study Site, New York
  • Akero Clinical Study Site, New York
  • Akero Clinical Study Site, New York
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

A’ fastadhÌre 3
  • GSK Investigational Site, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221188

Human Models of Selective Insulin Resistance: Alpelisib, Part I

A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
  • Columbia University Irving Medical Center, New York
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT06354088

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

A’ fastadhÌre 2
  • GSK Investigational Site, New York
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

A’ fastadhÌre 3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

A’ fastadhÌre 2
  • GSK Investigational Site, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043

Effect of Insulin Lowering on Lipogenesis

A’ fastadhÌre 1
  • Columbia University Irving Medical Center, New York
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT07403604

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

A’ fastadh
  • Icahn School of Medicine at Mount Sinai, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04054310

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

A’ fastadhFàilte do shaor-thoilich fhallain
  • Weill Cornell Medicine, New York
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT05332613

High Fructose Diet, the Gut Microbiome, and Metabolic Health

A’ fastadhFàilte do shaor-thoilich fhallain
  • Mount Sinai Morningside, New York
Aoisean 25 gu 45 · Gach gnè · Air ùrachadh 17 Dùbh 2025 · NCT06329544

Sgrùdaidhean Galar Ae Steatotic ann am bailtean eile

Sgrùdaidhean eile ann an New York City

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.